Hemab
Ashley Gosnell, MPAS, PA-C, serves as Senior Manager of Clinical Research, where she brings over a decade of unique healthcare and biotech experiences, ranging from clinical research and trial management to surgical procedures and diagnostics, to the Hemab team. She received an MSc in Physician Assistant Studies from South College in Knoxville, TN.
This person is not in any offices
Hemab
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.